Triflupromazine versus pentylenetetrazol-nicotinic acid for treatment of chronic brain disease on a general-hospital psychiatric service

J Am Geriatr Soc. 1969 Apr;17(4):414-20. doi: 10.1111/j.1532-5415.1969.tb05364.x.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Dementia / drug therapy*
  • Female
  • Humans
  • Intracranial Arteriosclerosis / drug therapy*
  • Male
  • Nicotinic Acids / adverse effects
  • Nicotinic Acids / therapeutic use*
  • Pentylenetetrazole / adverse effects
  • Pentylenetetrazole / therapeutic use*
  • Psychiatric Status Rating Scales
  • Psychological Tests
  • Time Factors
  • Triflupromazine / adverse effects
  • Triflupromazine / therapeutic use*

Substances

  • Nicotinic Acids
  • Triflupromazine
  • Pentylenetetrazole